Network models in drug discovery and regenerative medicine

Biotechnology Annual Review

Volumn 14, Issue , 2008, Pages 143-170

  Winkler, David A ^a  

^a CSIRO   (Australia)

Author keywords

Bayesian methods; cancer; feature selection; networks; QSAR; stem cells

Indexed keywords

BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOMATERIAL; CHOLINERGIC RECEPTOR BLOCKING AGENT; DRUG; ESTROGEN; GLUCOCORTICOID; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTIFICIAL NEURAL NETWORK; DRUG DESIGN; DRUG TARGETING; GENE REGULATORY NETWORK; GENOME; HUMAN; MATHEMATICAL MODEL; MOLECULE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGENERATIVE MEDICINE; REVIEW; STEM CELL;

ANIMALS; COMPUTER SIMULATION; DRUG DESIGN; HUMANS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PROTEOME; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION;

EID: 46149125735     PISSN: 13872656     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1387-2656(08)00005-7     Document Type: Review

References (126)

1. Korcsmaros T., Szalay M.S., Bode C., Kovacs I.A., and Csermely P. How to design multi-target drugs: target search options in cellular networks. Expert Opin on Drug Discov 2 (2007) 1-10
2. Winkler D.A., and Burden F.R. Bayesian neural networks for modelling in drug discovery (invited review). Biosilico 2 (2004) 104-111
3. Winkler D.A. Neural networks in ADME and toxicity prediction. Drugs Future 29 10 (2004) 1043-1057
4. Winkler D.A. Neural networks as robust tools in drug lead discovery and development. Mol Biotechnol 27 2 (2004) 139-167
5. Terfloth L., and Gasteiger J. Neural networks and genetic algorithms in drug design. Drug Discov Today 6 15 (2001) S102-S108
6. Sardari S., and Sardari D. Applications of artificial neural network in AIDS research and therapy. Curr Pharm Des 8 8 (2002) 659-670
7. Manallack D.T., and Livingstone D.J. Neural networks in drug discovery: have they lived up to their promise?. Eur J Med Chem 34 3 (1999) 195-208
8. Livingstone D.J., Manallack D.T., and Tetko I.V. Data modelling with neural networks: advantages and limitations. J Comput Aided Mol Des 11 2 (1997) 135-142
9. Aoyama T., and Ichikawa H. Neural networks applied to pharmaceutical problems. 5. Obtaining the correlation indexes between drug activity and structural parameters using a neural network. Chem Pharm Bull(Tokyo) 39 2 (1991) 372-378
10. Gasteiger J., Teckentrup A., Terfloth L., and Spycher S. Neural networks as data mining tools in drug design. J Phys Org Chem 16 4 (2003) 232-245
11. Gasteiger J and Li X. The Mapping of Molecular Electrostatic Potentials by Kohonen-Networks Investigations of Neurotransmitters and their Agonists. In: Software-Development in Chemistry, GDCH, Frankfurt/Main, 1993, Vol. 7, pp. 1-14.
12. Schneider G. Neural networks are useful tools for drug design. Neur Net 13 (2000) 13-15
13. Anzali S., Gasteiger J., Holzgrabe U., Polanski J., Sadowski J., Teckentrup A., and Wagener M. The use of self-organizing neural networks in drug design. Perspect Drug Discov Des 9-11 (1998) 273-299
14. van Osdol W.W., Myers T.G., and Weinstein J.N. Neural network techniques for informatics of cancer drug discovery. Numer Comp Methods, Part C 321 (2000) 369-395
15. Hopkins A.L. Network pharmacology. Nat Biotechnol 25 10 (2007) 1110-1111
16. Kitano H. A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov 6 (2007) 202-210
17. Sharom J.R., Bellows D.S., and Tyers M. From large networks to small molecules. Curr Opin Chem Biol 8 (2004) 81-90
18. Yildirim M.A., Goh K.I., Cusick M.E., Barabasi A.L., and Vidal M. Drug-target network. Nat Biotechnol 25 10 (2007) 1119-1126
19. Hopkins A.L., Mason J.S., and Overington J.P. Can we rationally design promiscuous drugs?. Curr Opin Struct Biol 16 1 (2006) 127-136
20. Smith J.R., Kholodovych V., Knight D., Welsh W.J., and Kohn J. QSAR models for the analysis of bioresponse data from combinatorial libraries of biomaterials. QSAR Comb Sci 24 1 (2005) 99-113
21. Finnigan J. The science of complex systems. Aust Sci June (2005) 32-34
22. Strogatz S.H. Exploring complex networks. Nature 410 (2001) 268-276
23. Wagner A., and Fell D.A. The small world inside large metabolic networks. Proc R Soc Lond B 268 (2001) 1803-1810
24. Arita M. Scale-freeness and biological networks. J Biochem 138 (2005) 1-4
25. Avnir D., Bihan O., and Malcai O. Is the geometry of nature fractal?. Nature 279 5347 (1998) 39-40
26. de Arcangelis L., and Herrmann H.J. Self-organized criticality on small world networks. Physica A 308 1-4 (2002) 545-549
27. Stanley H.E., Amarala L.A.N., Gopi Krishnan P., Ivanova P.C., Keittb T.H., and Plerou V. Scale invariance and universality: organizing principles in complex systems. Physica A 281 (2000) 60-68
28. Newman M.E.J. The structure and function of complex networks. SIAM Rev 45 2 (2003) 167-256
29. Bemis G.W., and Murcko M.A. The properties of known drugs. 1. Molecular frameworks. J Med Chem 39 15 (1996) 2887-2893
30. Zhang Z., and Grigorov M.G. Similarity networks of protein binding sites. Proteins 62 (2006) 470-478
31. Garcia-Domenech R., Galvez J., de Julian-Ortiz J.V., and Pogliani L. Some new trends in chemical graph theory. Chem Rev 108 3 (2008) 1127-1169
32. Salerno W., Havlak P., and Miller J. Scale-invariant structure of strongly conserved sequence in genomic intersections and alignments. Proc Natl Acad Sci USA 103 35 (2006) 13121-13125
33. Albert R., Jeong H., and Barabási A.-L. Error and attack tolerance of complex networks. Nature 406 (2000) 378-382
34. Lim J., Hao T., Shaw C., Patel A.J., Szabó G., Rual J.-F., Fisk J., Li N., Smolyar A., Hill D.E., Barabási A.-L., Vidal M., and Zoghbi H.Y. A protein-protein interaction network for human inherited ataxias and disorders of purkinje cell degeneration. Cell 125 (2006) 801-814
35. Loscalzo J., Kohane I., and Barabasi A. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol 3 (2007) 124
36. Winkler D.A., and Burden F.R. Application of neural networks to large dataset QSAR, virtual screening and library design (invited review). In: Bellavance-English L. (Ed). Combinatorial Chemistry Methods and Protocols (2002), Humana Press, Totowa, New Jersey ISBN 0-89603-980-3
37. Winkler D.A., and Burden F.R. Robust QSAR models from novel descriptors and Bayesian Regularized Neural Networks. Mol Simul 24 4-6 (2000) 243-258
38. Barrett C.L., Herring C.D., Reed J.L., and Palsson B.O. The global transcriptional regulatory network for metabolism in Escherichia coli exhibits few dominant functional states. Proc Natl Acad Sci USA 102 52 (2005) 19103-19108
39. Csete M., and Doyle J. Bow ties, metabolism and disease. Trends Biotechnol 22 9 (2004) 446-450
40. Csete M.E., and Doyle J.C. Reverse engineering of biological complexity. Science 295 5560 (2002) 1664-1669
41. Israeli N and Goldenfeld N. Coarse-graining of cellular automata, emergence, and the predictability of complex systems. Phys Rev E 2006;73:026203-1-026203-17.
42. Lovell-Badge R. Overview: The future for stem cell research. Nature 414 1 November (2001) 88-91
43. Kohn J., Welsh W.J., and Knight D. A new approach to the rationale discovery of polymeric biomaterials. Biomaterials 28 29 (2007) 4171-4177
44. Ge H., Liu Z., Church G.M., and Vidal M. Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat Genet 29 (2001) 482-486
45. Ito T., Chiba T., Ozawa R., Yoshida M., Hattori M., and Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA 98 (2001) 4569-4574
46. Chew J.L., Loh Y.-H., Zhang W., Chen X., Tam W.-L., Yeap L.-S., Li P., Ang Y.-S., Lim B., Robson P., and Ng H.-H. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 25 14 (2005) 6031-6046
47. Zhu J., and Emerson S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 21 (2002) 3295-3313
48. Gangenahalli G.U., Gupta P., Saluja D., Verma Y.K., Kishore V., Chandra R., Sharma R.K., and Ravindranath T. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis. Stem Cells Dev 14 (2005) 140-152
49. Orkin S.H. Chipping away at the embryonic stem cell network. Cell 122 6 (2005) 828-830
50. Rothenberg E.V., Telfer J.C., and Anderson M.K. Transcriptional regulation of lymphocyte lineage commitment. BioEssays 21 9 (1999) 726-742
51. Pan G.J., and Thomson J.A. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17 1 (2007) 42-49
52. Wang Z.X., The C.H.-L., Kueh J.L.L., Lufkin T., Robson P., and Stanton L.W. Oct4 and sox2 directly regulate expression of another pluripotency transcription factor, Zfp206, in embryonic stem cells. J Biol Chem 282 17 (2007) 12822-12830
53. Rodda D.J., Chew J.-L., Lim L.-H., Loh Y.-H., Wang B., Ng H.-H., and Robson P. Transcriptional regulation of Nanog by Oct4 and Sox2. J Biol Chem 280 26 (2005) 24731-24737
54. Player A., Wang Y., Bhattacharya B., Rao M., Puri R.K., and Kawasaki E.S. Comparisons between transcriptional regulation and RNA expression in human embryonic stem cell lines. Stem Cells Dev 15 3 (2006) 315-323
55. Sun Y., Li H., Yang H., Rao M.S., and Zhan M. Mechanisms controlling embryonic stem cell self-renewal and differentiation. Crit Rev Eukaryot Gene Expr 16 3 (2006) 211-231
56. Stein M.I., Zhu J., and Emerson S.G. Molecular pathways regulating the self-renewal of hematopoietic stem cells. Exp Hematol 32 12 (2004) 1129-1136
57. Halley JD, Winkler DA, Burden FR. Towards a Rosetta stone for the stem cell genomestochastic gene expression, network architecture and external influences. Stem Cell Res 2008, in press.
58. Hart C.E., Mjolsness E., and Wold B.J. Transcription network: inferences from neural networks. PloS Comput Biol 2 (2006) 1592-1607
59. Winkler DA, Burden FR and Halley JD. Modelling and predicting gene expression and fate decisions in mouse embryogenesis. Stem Cell Res, 2008, submitted.
60. Winkler DA, Burden FR and Halley JD. Using recursive networks to describe and predict gene expression and fate decisions during C. elegans embryogenesis. Artif Life, 2007, submitted.
61. Dutta D., Guha R., Wild D., and Chen T. Ensemble feature selection: consistent descriptor subsets for multiple QSAR models. J Chem Inf Model 47 3 (2007) 989-997
62. Liu Y. A comparative study on feature selection methods for drug discovery. J Chem Inf Model 44 (2004) 1823-1828
63. Saeys Y., Inza I., and Larranaga P. A review of feature selection techniques in bioinformatics. Bioinformatics 23 19 (2007) 2507-2517
64. Topliss J.G., and Costello R.J. Chance correlations in structure-activity studies using multiple regression analysis. J Med Chem 15 10 (1972) 1066-1068
65. Cramer III R.D., Patterson D.E., and Bunce J.D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110 18 (1988) 5959-5967
66. Tetko I.V., Gasteiger J., Todeschini R., Mauri A., Livingstone D., Ertl P., Palyulin V.A., Radchenko E.V., Zefirov N.S., Makarenko A.S., Tanchuk V.Y., and Prokopenko V.V. Virtual computational chemistry laboratory - design and description. J Comput Aided Mol Des 19 (2005) 453-463
67. Platt D.E., Parida L., Gao Y., Floratos A., and Rigoutsos I. QSAR in grossly underdetermined systems: opportunities and issues. IBM J Res Dev 45 3/4 (2001) 533-544
68. Figueiredo M.A.T. Adaptive sparseness for supervised learning. IEEE Trans Pattern Anal Mach Intell 25 (2003) 1150-1159
69. Bienfait B. Applications of high-resolution self-organizing maps to retrosynthetic and qsar analysis. J Chem Inf Comput Sci 34 4 (1994) 890-898
70. Bienfait B., and Gasteiger J. Checking the projection display of multivariate data with colored graphs. J Mol Graph Model 15 4 (1997) 203-215
71. Gasteiger J. Chemoinformatics in drug design. Drugs Future 32 Suppl. (2007) A-2
72. Gasteiger J., Li X.Z., and Uschold A. The beauty of molecular-surfaces as revealed by self-organizing neural networks. J Mol Graph 12 2 (1994) 90-97
73. Gasteiger J., and Zupan J. Neural networks in chemistry. Angew Chem Int Ed Engl 32 4 (1993) 503-527
74. Kaiser D., Terfloth L., Kopp S., Schulz J., de Laet R., Chiba P., Ecker G.F., and Gasteiger J. Self-organizing maps for identification of new inhibitors of P-glycoprotein. J Med Chem 50 7 (2007) 1698-1702
75. Stark J., Callard R., and Hubank M. From the top down: towards a predictive biology of signalling networks. TRENDS in Biotechnol 21 7 (2003) 290-293
76. Khan J., Wei J.S., Ringnér M., Saal L.H., Ladanyi M., Westermann F., Berthold F., Schwab M., Antonescu C.R., Peterson C., and Meltzer P.S. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7 (2001) 673-679
77. Burden FR, Winkler DA and Halley JD. Diagnosis of small round blue cell tumours using microarrays and sparse methods. Int J Cancer, 2008, submitted.
78. Laslett A.L., Grimmond S., Gardiner B., Stamp L., Lin A., Hawes S.M., Wormald S., Nikolic-Paterson D., Haylock D., and Pera M.F. Transcriptional analysis of early lineage commitment in human embryonic stem cells. BMC Dev Biol 7 (2007) 12-30
79. Xiong M.M., Li J., and Fang X.Z. Identification of genetic networks. Genetics 166 2 (2004) 1037-1052
80. Husmeier D. Sensitivity and specificity of inferring genetic regulatory interactions from microarray experiments with dynamic Bayesian networks. Bioinformatics 19 17 (2003) 2271-2282
81. Husmeier D. Reverse engineering of genetic networks with Bayesian networks. Biochem Soc Trans 31 (2003) 1516-1518
82. Huang Z., Li J., Su H., Watts G.S., and Chen H. Large-scale regulatory network analysis from microarray data: modified Bayesian network learning and association rule mining. Decision Support Syst 43 4 (2007) 1207-1225
83. Gupta R.R., and Achenie L.E.K. A network model for gene regulation. Comput Chem Eng 31 8 (2007) 950-961
84. Huang S. Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. Pharmacogenomics 2 3 (2001) 203-222
85. Kauffman S. The ensemble approach to understand genetic regulatory networks. Physica a-Stat Mech App 340 4 (2004) 733-740
86. Kauffman S., Peterson C., Samuelsson B., and Troein C. Random Boolean network models and the yeast transcriptional network. Proc Natl Acad Sci USA 100 25 (2003) 14796-14799
87. Cheng J and Greiner R. Learning Bayesian belief network classifiers algorithms and system. Advances in Artificial Intelligence Proceeding of the 14th Biennial Conference of the Canadian Society for Computational Studies of Intelligence (Stroulia E and Matwin S, eds), Ottawa, 7-9 June 2001, Springer-Verlag, Berlin, pp. 141-151.
88. Ray S.S., Bandyopadhyay S., Mitra P., and Pal S.K. Bioinformatics in neurocomputing framework. IEE Proc.-Circuits Devices Syst 152 5 (2005) 556-564
89. Friedman N., Linial M., Nachman I., and Pe'er D. Using Bayesian networks to analyze expression data. J Comput Biol 7 3-4 (2000) 601-620
90. Geard N., and Wiles J. A gene network model for developing cell lineages. Artif Life 11 3 (2005) 249-267
91. Zernicka-Goetz M. Cleavage pattern and emerging asymmetry of the mouse embryo. Nat Rev Mol Cell Biol 6 December (2005) 919-928
92. Hamatani T., Carter M., Sharov A., and Ko M. Dynamics of global gene expression changes during mouse preimplantation development. Dev Cell 6 1 (2004) 117-131
93. Hart C.E., Mjolsness E., and Wold B.J. Connectivity in the yeast cell cycle transcription network: inferences from neural networks. Plos Comput Biol 2 12 (2006) 1592-1607
94. Winkler D. The broader applications of neural and genetic modelling methods. Drug Discov Today 6 23 (2001) 1198-1199
95. Ford M.G., Pitt W.R., and Whitley D.C. Selecting compounds for focused screening using linear discriminant analysis and artificial neural networks. J Mol Graph Model 22 6 (2004) 467-472
96. Burden F.R., and Winkler D.A. New QSAR methods applied to structure-activity mapping and combinatorial chemistry. J Chem Inf Comput Sci 39 2 (1999) 236-242
97. Burden F.R., and Winkler D.A. Robust QSAR models using Bayesian regularized neural networks. J Med Chem 42 16 (1999) 3183-3187
98. Agrafiotis D.K., Cedeno W., and Lobanov V.S. On the use of neural network ensembles in QSAR and QSPR. J Chem Inf Comput Sci 42 4 (2002) 903-911
99. Ajay A. Unified framework for using neural networks to build QSARs. J Med Chem 36 23 (1993) 3565-3571
100. Basak S.C., Grunwald G.D., Gute B.D., Balasubramanian K., and Opitz D. Use of statistical and neural net approaches in predicting toxicity of chemicals. J Chem Inf Comput Sci 40 4 (2000) 885-890
101. Di Fenza A., Alagona G., Ghio C., Leonardi R., Giolitti A., and Madami A. Caco-2 cell permeability modelling: a neural network coupled genetic algorithm approach. J Comput Aided Mol Des 21 4 (2007) 207-221
102. Salt D.W., Yildiz N., Livingstone D.J., and Tinsley C.J. The use of artificial neural networks in QSAR. Pestic Sci 36 2 (1992) 161-170
103. Penzotti J.E., Landrum G.A., and Putta S. Building predictive ADMET models for early decisions in drug discovery. Curr Opin Drug Discov Devel 7 1 (2004) 49-61
104. Weaver D.C. Applying data mining techniques to library design, lead generation and lead optimization. Curr Opin Chem Biol 8 3 (2004) 264-270
105. Perkins R., Fang H., Tong W., and Welsh W.J. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology. Environ Toxicol Chem 22 8 (2003) 1666-1679
106. Winkler D.A., and Burden F.R. Modelling blood-brain barrier partitioning using Bayesian neural nets. J Mol Graph Model 22 6 (2004) 499-505
107. Polley M.J., Winkler D.A., and Burden F.R. Broad-based quantitative structure-activity relationship modeling of potency and selectivity of farnesyltransferase inhibitors using a Bayesian regularized neural network. J Med Chem 47 25 (2004) 6230-6238
108. Polley M.J., Burden F.R., and Winkler D.A. Predictive human intestinal absorption QSAR models using Bayesian regularized neural networks. Aust J Chem 58 12 (2005) 859-863
109. Burden F.R., and Winkler D.A. A quantitative structure-activity relationships model for the acute toxicity of substituted benzenes to Tetrahymena pyriformis using Bayesian-regularized neural networks. Chem Res Toxicol 13 6 (2000) 436-440
110. Burden F.R., and Winkler D.A. Predictive Bayesian neural network models of MHC class II peptide binding. J Mol Graph Model 23 6 (2005) 481-489
111. Caballero J., and Fernandez M. Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks. J Mol Model 12 2 (2006) 168-181
112. Caballero J., Garriga M., and Fernandez M. 2D autocorrelation modeling of the negative inotropic activity of calcium entry blockers using Bayesian-regularized genetic neural networks. Bioorg Med Chem 14 10 (2006) 3330-3340
113. Fernandez M., and Caballero J. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives. Bioorg Med Chem 15 18 (2007) 6298-6310
114. Fernandez M., and Caballero J. QSAR models for predicting the activity of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A using quantum chemical properties. J Mol Model 13 4 (2007) 465-476
115. Fernandez M., Carreiras M.C., Marco J.L., and Caballero J. Modeling of acetylcholinesterase inhibition by tacrine analogues using Bayesian-regularized Genetic Neural Networks and ensemble averaging. J Enzyme Inhib Med Chem 21 6 (2006) 647-661
116. Gonzalez M.P., Caballero J., Tundidor-Camba A., Helguera A.M., and Fernández M. Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches. Bioorg Med Chem 14 1 (2006) 200-213
117. Xu M., Zeng G., Xu X., Huang G., Jiang R., and Sun W. Application of Bayesian regularized BP neural network model for trend analysis, acidity and chemical composition of precipitation in North Carolina. Water Air Soil Pollut 172 1-4 (2006) 167-184
118. Xu M., Zeng G.-M., Xu X.-Y., Huang G.-H., Sun W., and Jiang X.-Y. Application of Bayesian regularized BP neural network model for analysis of aquatic ecological data - A case study of chlorophyll-a prediction in Nanzui water area of Dongting Lake. J Environ Sci (China) 17 6 (2005) 946-952
119. Niculescu S.P. Artificial neural networks and genetic algorithms in QSAR. J Mol Struct Theochem 622 1-2 (2003) 71-83
120. Martynenko A., Yang S.X., and Pan L. Intelligent computation of moisture content in shrinkable biomaterials. Drying Technol 25 10 (2007) 1667-1676
121. Lucchinetti E., and Stussi E. Prediction of elasticity constants in small biomaterial samples such as bone. A comparison between classical optimization techniques and identification with artificial neural networks. Proc Inst Mech Eng [H] 218 H6 (2004) 389-405
122. Kaminski W., Strumiłło P., Tomczak E., and Zbicinsk I. Modelling of thermal degradation process dynamics of bioproducts using artificial neural networks. J Syst Eng 6 3 (1996) 159-165
123. Gubskaya A.V., Kholodovych V., Knight D., Kohn J., and Welsh W.J. Prediction of fibrinogen adsorption for biodegradable polymers: integration of molecular dynamics and surrogate modeling. Polymer 48 19 (2007) 5788-5801
124. Schut J., Bolikal D., Khan I.J., Pesnell A., Rege A., Rojas R., Sheihet L., Murthy N.S., and Kohn J. Glass transition temperature prediction of polymers through the mass-per-flexible-bond principle. Polymer 48 20 (2007) 6115-6124
125. Smith J.R., Kholodovych V., Knight D., Kohn J., and Welsh W.J. Predicting fibrinogen adsorption to polymeric surfaces in silico: a combined method approach. Polymer 46 12 (2005) 4296-4306
126. Smith J.R., Knight D., Kohn J., Rasheed K., Weber N., Kholodovych V., and Welsh W.J. Using surrogate modeling in the prediction of fibrinogen adsorption onto polymer surfaces. J Chem Inf Comput Sci 44 3 (2004) 1088-1097